thiabendazole has been researched along with B16 Melanoma in 1 studies
Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, J | 1 |
Zhao, C | 1 |
Gao, Y | 1 |
Jiang, Y | 1 |
Liang, H | 1 |
Zhao, G | 1 |
1 other study available for thiabendazole and B16 Melanoma
Article | Year |
---|---|
Thiabendazole, a well-known antifungal drug, exhibits anti-metastatic melanoma B16F10 activity via inhibiting VEGF expression and inducing apoptosis.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell | 2013 |